##
##
##
##
|||Page|
|---|---|---|
|Reference and administrative
details ofthe charity,|its Trustees and advisers||
|Trustees'
report||2-3|
|Independent
examiner's
report|||
|Statement offinancial activities|||
|Balance sheet|||
|Notes to the financial statements||7-16|
##
|REFERENCE AND|REFERENCE AND|ADMINISTRATIVE|DETAILS OF|DETAILS OF|THE CHARITY, ITSTRUSTEES AND ADVISERS|
|---|---|---|---|---|---|
|||FOR THE||YEAR ENDED 30JUNE 2022||
|Trustees||G S Barham||||
|||R P Colman||||
|||Paul Nicolai||||
|||Anish Sang hrajka||||
|||J KTucker||||
|||A N Wright||||
|Charity registered||The Orthopaedics||Charitable|Trust Fund|
|name||||||
|Operating|name|The Orthopaedics|Trust|||
|Charity registered||||||
|number||1110248||||
|Principal|office|5The Close||||
|||Norwich||||
|||Norfolk||||
|||NR1 4DH||||
|Accountants||Larking Gowen|LLP|||
|||Chartered
Accountants||||
|||King Street House||||
|||15Upper King|Street|||
|||Norwich||||
|||NR3 1RB||||
|Bankers||Lloyds TSB||||
|||Surrey Street||||
|||Nonvich||||
|||NR1 3NF||||
|Stockbrokers||Barratt 8 Cooke||||
|||5 Opie Street||||
|||Norwich||||
|||NR1 3DW||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Unrestricted|Endowment|Total|Total|
|---|---|---|---|---|---|---|---|
|||||funds|funds|funds|funds|
|||||2022|2022|2022|2021|
||||Note||E|||
|Income and endowments||from:||||||
|Investments||||42,564||42,564|33,946|
|Total income and|endowments|||42,564||42,564|33,946|
|Expenditure
on:||||||||
|Charitable
activities||||(34,766)|564|(34,202)|165,339|
|Total expenditure||||(34,766)|564|(34,202)|165,339|
|Net income/(expenditure)
before net
(losses)/gains
on investments||||77,330|(564)|76,766|(131,393)|
|Net (losses)/gains|on investments|||(4,572)|(33,719)|(38,291)|101,584|
|Net movement
in|funds|||72,758|(34,283)|38,475|(29,809)|
|Reconciliation
of|funds:|||||||
|Total funds brought|forward||||1,263,231|1,263,231|1,293,040|
|Net movement
in funds||||72,758|(34,283)|38,475|(29,809)|
|Total funds carried forward||||72,758|1,228,948|1,301,706|1,263,231|
##
||||BALANCE SHEET||||
|---|---|---|---|---|---|---|
||||AS AT 30JUNE 2022||||
|||||2022||2021|
||||Note||||
|Fixed assets|||||||
|Investments||||1,293,687||1,434,509|
|||||1,293,687||1,434,509|
|Current assets|||||||
|Cash at bank and in hand|||119,413||83,000||
||||119,413||83,000||
|Creditors: amounts|falling due within one||||||
|year|||(93,739)||(236,623)||
|Net current assets I||liabilites||25,674||(153,623)|
|Total assets less|current liabilities|||1,319,361||1,280,886|
|Creditors: amounts|falling due after more||||||
|than one year|||10|(17,655)||(17,655)|
|Net assets excluding||pension asset||1,301,706||1,263,231|
|Total net assets||||1,301,706||1,263,231|
|Charity funds|||||||
|Endowment
funds||||1,228,948||'/,263,231|
|Unrestricted
funds||||72,758|||
|Total funds||||1,301,706||1,263,231|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Total|
|---|---|---|---|---|
||||funds|funds|
||||2021|2021|
|Dividend|income||27,341|27,341|
|Bank income|||1|1|
|Interest|bearing|securities|6,604|6,604|
||||33,946|33,946|
##
##
##
|||Grant|||
|---|---|---|---|---|
|||funding
of|Support|Total|
|||activities|costs|funds|
|||2022|2022|2022|
|||||R|
|Charitable|activities|(36,655)|2,453|(34,202)|
|||Grant|||
|||funding of|Support|Tota/|
|||activities|costs|funds|
|||2021|2021f|2021|
|Charitable|activities|163,189|2,150|165,339|
##
##
|4.|Analysis ofgrants|||||
|---|---|---|---|---|---|
|||||2022|2021|
||NNUH - research
into the CAPability
study to evaluate
patient outcomes|||||
||(IM)||||64,596|
||Oxford University
Nuffield
Department
of Orthopaedics,
Rheumatology|||||
||and Musculoskeletal
Sciences - research
into the use of mapping
existing|||||
||ankle replacement
data using worldwide
national
joint registries (TP)||||3,230|
||Cambridge
University
Department
of Surgery - research
into the reparative|||||
||potential
of skeletal
stem/progenitor
cells from anatomically|distinct sites||||
||(EA)||||12,420|
||UCL - research
into the retrieval
analysis of newly introduced
implants|||||
||(HH)||||26,650|
||Enhanced
Post Market surveillance
ofAdditive
Manufactured
Orthopaedic|||||
||Implants
(HH)|||7,365||
||Manchester
University
- research
into tissue retrieval
and analysis to|||||
||understand
mechanisms
offailure to cartilege repair surgeries (LB)||||32,398|
||Cambridge
University
Teaching
Hospitals
NHS Foundation|Trust-||||
||research
tnto the use ofaugmented
shoulder
arthroplasty,|revealing|the|||
||camouflaged
data (MD)||||1,740|
||UEA Department
of Biological Science for research
into establishing|||||
||inhibition
of MMP-14 as a viable therapeutic
in Dupuytren's|disease (MP)|||17,655|
||Using Machine Learning to detect and predict loosening
of|the femoral||||
||component
ofan uncemented
total hip replacement
(VP)|||4,309||
||University
of Nottingham
Department
of Orthopaedics
and|Trauma-||||
||research
into the outcomes following
total hip replacement|for trauma||||
||using NJR data (BM)||||1,740|
||Royal Devon and Exeter Hospital - 5year survivorship
of total ankle|||||
||replacements
(TJ)||||2,760|
||Grants withdrawn|||(48,329)||
|||||(36,655)|163,189|
|5.|Net incoming
resourcesl (resources expended)|||||
|||||2022f|2021|
||Independent
examiners
remuneration|||1,560|1,422|
##
##
||||Unrestricted|Endowment|Total|
|---|---|---|---|---|---|
||||funds|funds|funds|
||||2022|2022|2022|
|Barratt 8 Cooke Nominee||Fees||564|564|
|Accountancy|& Independent|Exam fees|1,560||1,560|
|Miscellaneous|expenses||329||329|
|Total 2022|||1,889|564|2,453|
||||Unrestricted|Endowment|Total|
||||funds|funds|funds|
||||2021|2021|2021|
|Barratt &Cooke Nominee||Fees||528|528|
|Accountancy|8 Independent|Exam fees|1,422||1,422|
|Clerks honorarium|||200||200|
|Total 2021|||1,622|528|2,150|
##
##
##
##
||Listed|
|---|---|
||securities|
|Cost or valuation||
|At 1 July 2021|1,434,509|
|Additions|224,101|
|Disposais|(326,632)|
|Revaluations|(38,291)|
|At 30June 2022|1,293,687|
|Net book value||
|At 30June 2022|1,293,687|
|Af 30June 2021|1,434,509|
##
|||2022|2021|
|---|---|---|---|
|Grant creditors||92,179|235,201|
|Accruals and deferred|income|1,560|1,422|
|||93,739|236,623|
##
|||2022|2021f|
|---|---|---|---|
|Grant|creditors|17,655|17,655|
##
##
##
|Statemen|t|offunds - cur|rent year|||||
|---|---|---|---|---|---|---|---|
||||||||Balance at|
||||Balance at 1|||Gains/|30June|
||||July 2021|Income|Expenditure|(Losses)|2022|
||||E||E||f.|
|Unrestricted||funds||||||
|General|Funds|||42,564|34,766|(4,572)|72,758|
|Endowment||funds||||||
|Endowment||Fund|'l,263,231||(564)|(33,719)|1,228,948|
|Total of|funds||1,263,231|42,564|34,202|(38,291)|1,301,706|
##
##
##
|Statemen|t offun|ds - prior year||||||
|---|---|---|---|---|---|---|---|
||||||||Balance at|
|||Balance at|||Transfers|Gainsl|30June|
|||1July 2020|Income|Expenditure|inlout|(Losses)|2021|
|Unrestricted||||||||
|funds||||||||
|General|Funds||33,946|(164,811)|125,652|5,213||
|Endowment||||||||
|funds||||||||
|Endowment||||||||
|Fund||1,293,040||(528)|(125,652)|96,371|1,263,231|
|Total of|funds|1,293,040|33,946|(165,339)||101,584|1,263,231|
##
##
##
##
||Unrestricted|Endowment|Total|
|---|---|---|---|
||funds|funds|funds|
||2022|2022|2022|
|Fixed asset investments|64,739|1,228,948|1,293,687|
|Current assets|119,413||119,413|
|Creditors due within one year|(93,739)||(93,739)|
|Creditors due in more than one year|(17,655)||(17,655)|
|Total|72,758|1,228,948|1,301,706|
##
|Analysis ofnet assets between funds - prior y|ear|||
|---|---|---|---|
||Unrestricted|Endowment|Total|
||funds|funds|funds|
||2021|2021|2021|
|Fixed asset investments|171,278|1,263,231|1,434,509|
|Current assets|83,000||83,000|
|Creditors due within one year|(236,623)||(236,623)|
|Creditors due in more than one year|(17,655)||(17,655)|
|Total||1,263,231|1,263,231|
##